<a href=\"/content/nemours/us/en.html\">91大神 Children's Health</a> | <a href=\"https://kidshealth.org/\">91大神 KidsHealth</a> </p>\r\n"}} id=text-b0f8b48d01 class=cmp-text>
Trial of Lenalidomide in Patients With Juvenile Pilocytic Astrocytomas & Optic Pathway Gliomas
Clinical Trial</h3>\r\n<p><b>Offered by:</b> 91大神 Children's<br>\r\n<b>Locations:</b> Delaware Valley and Pensacola, Florida</p>\r\n<h3>Trial Name</h3>\r\n<p>A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas</p>\r\n<h3>What is the trial about?<br>\r\n</h3>\r\n<p>To find out what effects low and high doses of lenalidomide have on children, adolescents, and young adults with recurrent/refractory/progressive JPA or OPG.</p>\r\n<h3>Who can participate?<br>\r\n</h3>\r\n<p>Children with juvenile pilocytic astrocytomas (JPA) or an optic pathway glioma (OPG).</p>\r\n<h3>What is involved?</h3>\r\n<p style=\"margin-bottom: 24.0px;\">Length of study is 24 months. Standard cancer care.</p>\r\n"}} id=text-efc2582bc1 class=cmp-text>
What is the trial about?
Who can participate?
Clinical Trial
Offered by: 91大神 Children's
Locations: Delaware Valley and Pensacola, Florida
Trial Name
A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
What is the trial about?
To find out what effects low and high doses of lenalidomide have on children, adolescents, and young adults with recurrent/refractory/progressive JPA or OPG.
Who can participate?
Children with juvenile pilocytic astrocytomas (JPA) or an optic pathway glioma (OPG).
What is involved?
Length of study is 24 months. Standard cancer care.
Contact 91大神 Children's Clinical Trials
<strong>Trial Name:</strong> A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas</p>\r\n<p><strong>ACNS#: </strong>1022</p>\r\n"}} id=text-91f8153705 class=cmp-text>
Trial Name: A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
ACNS#:听1022
Is a Clinical Trial Right for Your Child?</h2>"}} id=text-ed72434012 class=cmp-text>
Is a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.</p>\r\n"}} id=text-71d2b4a18f class=cmp-text>
Learn more about clinical trials and get answers to questions you might have.
